165 related articles for article (PubMed ID: 28475750)
21. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
22. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
[TBL] [Abstract][Full Text] [Related]
24. Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.
Ge Y; Liu J; Yang X; Zhu H; Yang B; Zhao K; Wu Z; Cheng G; Wang F; Ni F; Ge Q; Yang Y; Tai G; Sun X; Cai J
Tumour Biol; 2014 Nov; 35(11):10765-71. PubMed ID: 25073512
[TBL] [Abstract][Full Text] [Related]
25. Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis.
Liu J; Ge YY; Zhu HC; Yang X; Cai J; Zhang C; Lu J; Zhan LL; Qin Q; Yang Y; Yang YH; Zhang H; Chen XC; Liu ZM; Ma JX; Cheng HY; Sun XC
Asian Pac J Cancer Prev; 2014; 15(16):6649-55. PubMed ID: 25169503
[TBL] [Abstract][Full Text] [Related]
26. Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines.
Ribeiro JC; Barnetson AR; Jackson P; Ow K; Links M; Russell PJ
Int J Radiat Biol; 1999 Apr; 75(4):481-92. PubMed ID: 10331854
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
[TBL] [Abstract][Full Text] [Related]
28. BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation.
Wang XT; Bao CH; Jia YB; Wang N; Ma W; Liu F; Wang C; Wang JB; Song QX; Cheng YF
Biochem Biophys Res Commun; 2014 Oct; 452(4):945-50. PubMed ID: 25223594
[TBL] [Abstract][Full Text] [Related]
29. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
30. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest.
Zhao PJ; Song SC; Du LW; Zhou GH; Ma SL; Li JH; Feng JG; Zhu XH; Jiang H
Mol Med Rep; 2016 Mar; 13(3):2878-84. PubMed ID: 26846193
[TBL] [Abstract][Full Text] [Related]
31. miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21.
Zheng R; Liu Y; Zhang X; Zhao P; Deng Q
Biomed Pharmacother; 2017 Jun; 90():517-523. PubMed ID: 28402920
[TBL] [Abstract][Full Text] [Related]
32. ZNF468 inhibits irradiation-induced G2/M cell cycle arrest and apoptosis by facilitating AURKA transcription in Esophageal Squamous Cell Carcinoma.
Bai G; Mahati S; Tulahong A; Eli M; Mao R
Biochem Biophys Res Commun; 2024 Apr; 703():149687. PubMed ID: 38368674
[TBL] [Abstract][Full Text] [Related]
33. Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells.
Ding WX; Liu S; Ma JX; Pu J; Wang HJ; Zhang S; Sun XC
Cancer Cell Int; 2019; 19():36. PubMed ID: 30820189
[TBL] [Abstract][Full Text] [Related]
34. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
35. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
36. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
[TBL] [Abstract][Full Text] [Related]
37. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity and radiosensitization effect of TRA-8 on radioresistant human larynx squamous carcinoma cells.
Wu F; Hu Y; Long J; Zhou YJ; Zhong YH; Liao ZK; Liu SQ; Zhou FX; Zhou YF; Xie CH
Oncol Rep; 2009 Feb; 21(2):461-5. PubMed ID: 19148523
[TBL] [Abstract][Full Text] [Related]
40. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation.
Cao Y; Gao A; Li X; Min H; He C; Sun X; Ding WQ; Zhou J
Cancer Med; 2021 May; 10(9):3101-3112. PubMed ID: 33787085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
